France launches campaign to curb overuse of anxiety and sleep medications
19 Articles
19 Articles
France launches campaign to curb overuse of anxiety and sleep medications
Amid rising concern over long-term use and side effects, France has launched a national campaign to raise awareness about the risks associated with commonly prescribed anti-anxiety and sleep medications such as Xanax, Lexomil and Temesta.
Xanax, Lexomil, Temesta: "3.6 million French take on too long periods"
From this Thursday, April 10, and for five weeks, the National Drug Safety Agency is launching an extensive information campaign to raise awareness of the proper use of benzodiazepines, often consumed over too long periods of time.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage